The APC-PCI concentration as an early marker of activation of blood coagulation: A study of women on combined oral contraceptives

Thrombosis Research

Volumn 130, Issue 4, 2012, Pages 636-639

  Bremme, K ^a   Hamad, R Rafik ^a   Berg, Elisabeth ^a   Strandberg, K ^b   Stenflo, J ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; D DIMER; DESOGESTREL; ETHINYLESTRADIOL; LEVONOGESTREL; ORAL CONTRACEPTIVE AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 3; THROMBIN ANTITHROMBIN COMPLEX; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; CROSSOVER PROCEDURE; FEMALE; FEMALE FERTILITY; HUMAN; MENSTRUAL CYCLE; NULLIPARA; ORAL CONTRACEPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

ADULT; ANTITHROMBIN III; BLOOD COAGULATION; CONTRACEPTIVES, ORAL, COMBINED; DESOGESTREL; ETHINYL ESTRADIOL; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; LEVONORGESTREL; PEPTIDE HYDROLASES; PROTEIN C; PROTEIN C INHIBITOR; THROMBOPHILIA; YOUNG ADULT;

EID: 84866256112     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.11.006     Document Type: Article

References (24)

1. E.F. van Vlijmen, J.L. Brouwer, N.J. Veeger, T.K. Eskes, P.A. de Graeff, and J. van der Meer Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study Arch Intern Med 167 3 Feb 12 2007 282 289
2. F.R. Rosendaal, A. Van Hylckama Vlieg, B.C. Tanis, and F.M. Helmerhorst Estrogens, progestogens and thrombosis J Thromb Haemost 1 7 Jul 2003 1371 1380
3. C.T. Esmon The protein C pathway Chest 124 3 Suppl. Sep 2003 26S 32S
4. J.H. Griffin, J.A. Fernandez, A.J. Gale, and L.O. Mosnier Activated protein C J Thromb Haemost 5 Suppl. 1 Jul 2007 73 80
5. B. Dahlback Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases J Intern Med 257 3 Mar 2005 209 223
6. M. Tanigawa, H. Wada, K. Minamikawa, Y. Wakita, S. Nagaya, and T. Mori Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction Am J Hematol 49 1 1995 May 1 5
7. F. Espana, V. Vicente, D. Tabernero, I. Scharrer, and J.H. Griffin Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease Thromb Res 59 3 1990 Aug 1 593 608
8. K. Minamikawa, H. Wada, Y. Wakita, M. Ohiwa, M. Tanigawa, and K. Deguchi Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism Thromb Haemost 71 2 1994 Feb 192 194
9. K. Strandberg, M. Kjellberg, R. Knebel, H. Lilja, and J. Stenflo A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor Thromb Haemost 86 2 2001 Aug 604 610
10. M. van Rooijen, A. Silveira, A. Hamsten, and K. Bremme Sex hormone-binding globulin-a surrogate marker for the prothrombotic effects of combined oral contraceptives Am J Obstet Gynecol 190 2 2004 Feb 332 337
11. K. Strandberg, A. Svensson, and J. Stenflo Stabilyte tubes that contain strongly acidic citrate prevent in vitro complex formation between activated protein C and protein C inhibitor Thromb Haemost 89 5 2003 May 947 949
12. K. Strandberg, M. Kjellberg, E.M. Erb, U. Persson, D.F. Mosher, and B.O. Villoutreix Activated protein C-protein C inhibitor complex formation: characterization of a neoepitope provides evidence for extensive insertion of the reactive center loop Biochemistry 39 51 2000 Dec 26 15713 15720
13. R. Kirk Experimental design: Procedures for the behavioural science 1995 Brooks/Cole Publishing Company Pacific Grove USA
14. R.C. Littell, George A. Milliken, Walter W. Stroup, Russell D. Wolfinger, and Oliver Schabenberger SAS System for Mixed Models second ed. 2006 SAS Institute Inc Cary,. NC
15. P. Bhiladvala, K. Strandberg, J. Stenflo, and J. Holm Early identification of acute myocardial infarction by activated protein C-protein C inhibitor complex Thromb Res 118 2 2006 213 219
16. J. Rosing, G. Tans, G.A. Nicolaes, M.C. Thomassen, R. van Oerle, and P.M. van der Ploeg Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives Br J Haematol 97 1 1997 Apr 233 238
17. H.A. van Vliet, R.M. Bertina, A.E. Dahm, F.R. Rosendaal, J. Rosing, and P.M. Sandset Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor J Thromb Haemost 6 2 2008 Feb 346 351
18. G. Tans, J. Curvers, S. Middeldorp, M.C. Thomassen, J.C. Meijers, and M.H. Prins A randomized cross-over study on the effects of levonorgestrel- and desogestrelcontaining oral contraceptives on the anticoagulant pathways Thromb Haemost 84 2000 15 21
19. G. Tans, A. van Hylckama Vlieg, M.C. Thomassen, J. Curvers, M. Bertina Rogier, and J. Rosing Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women Br J Haematol 122 2003 465 470
20. K. Strandberg, J. Stenflo, C. Nilsson, and P.J. Svensson APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden J Thromb Haemost 3 11 2005 Nov 2578 2580
21. J.C. Meijers, S. Middeldorp, W. Tekelenburg, A.E. van den Ende, G. Tans, and M.H. Prins Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of low-dose oral contraceptives Thromb Haemost 84 2000 9 14
22. S. Middeldorp, J.C. Meijers, A.E. van den Ende, A. van Enk, B.N. Bouma, and G. Tans Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study Thromb Haemost 84 1 2000 Jul 4 8
23. Svetlana N. Tchaikovski, Huib A.A.M. van Vliet, M. Thomassen, L.G.D. Christella, M. Bertina Rogier, R. Rosendaal Frits, and P.M. Sandset Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography Thromb Haemost 98 2007 1350 1356
24. K. Strandberg, J. Astermark, O. Bjorgell, C. Becker, P.E. Nilsson, and J. Stenflo Complexes between activated protein C and protein C inhibitor measured with a new method: comparison of performance with other markers of hypercoagulability in the diagnosis of deep vein thrombosis Thromb Haemost 86 6 Dec 2001 1400 1408